← Leaderboards
Neeta Jain
Vignet, Inc.
$45,195,150
Attributed
$191,139,999
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $46.9M · FY2020–25$50M$37.5M$25M$12.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$191,139,999 · 1
By mechanism
OT2$191,139,999 · 1
Top collaborators
- Mark Begale18 shared
- Praduman Jain18 shared
- Scott Andrew Sutherland18 shared
- Dave Klein1 shared
- Rachele Peterson1 shared
Most similar at Vignet, Inc.
Same institution · by research overlap
- Praduman Jain$157,180,930
- Mark Begale$45,195,150
- Scott Andrew Sutherland$45,195,150
Others in their field
Other Emerging Leaders on “Acceleration”
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$96,326,191
- Terry Drinkwine · Carahsoft Technology Corporation$93,741,163
- Mark Marino · Venturewell$61,502,138
- Klaus Romero · Critical Path Institute$58,665,332
Research focus
AccelerationAll Of Us Research ProgramProgramsRecruitResourcesSecurityServicesSuccessTechnologyCommunicationEcosystemEnrollmentFlexibilityGenomicsInnovationLeadLeadershipLearningMissionParticipantPrivacyPersonsBaseEnsure
Grant awards (18)
PTSC 2.0$1,499,573
OT2 · FY2025 · OD
PTSC 2.0$17,094,493
OT2 · FY2024 · OD
PTSC 2.0$26,078,422
OT2 · FY2023 · OD
PTSC 2.0$10,045,596
OT2 · FY2023 · OD
PTSC 2.0$5,268,448
OT2 · FY2023 · OD
PTSC 2.0$2,479,799
OT2 · FY2023 · OD
PTSC 2.0$25,464,516
OT2 · FY2022 · OD
PTSC 2.0$10,069,899
OT2 · FY2022 · OD
PTSC 2.0$4,850,000
OT2 · FY2022 · OD
PTSC 2.0$4,516,054
OT2 · FY2022 · OD
PTSC 2.0$1,990,662
OT2 · FY2022 · OD
PTSC 2.0$31,078,193
OT2 · FY2021 · OD
PTSC 2.0$4,166,064
OT2 · FY2021 · OD
PTSC 2.0$2,645,217
OT2 · FY2021 · OD
PTSC 2.0$2,549,098
OT2 · FY2021 · OD
PTSC 2.0$1,280,958
OT2 · FY2021 · OD
PTSC 2.0$39,063,007
OT2 · FY2020 · OD
PTSC 2.0$1,000,000
OT2 · FY2020 · OD